insulin can also (and usually is) given by subcutaneous injection, trying to administer an excess of 1000U of the rapid acting form of this drug, by the subcutaneous method can be practically im- possible.
The other issue is that the growing number of people with access to this drug have the form of the disease where their bodies are unresponsive to the drug (Type 2 diabetes). While 1000U admin- istered rapidly might peacefully end the life of a non-diabetic, those with the disease need to be much more careful.
In theory, one can pre-sensitise oneself, by taking alcohol (which restricts the body’s emergency release of sugar), fasting, and by the administration of a significant dose of oral hypoglycemics before the insulin is injected. (eg ~50mg Glimepiride), the risks and uncertainties of the administration of a large subcutaneous injection remain.
In the US, insulin can be imported if it is being prescribed and is for personal use. Outside of these circumstances, the penalty for importation is up to one years imprisonment and a $1,000 fine. In Australia, Insulin is a Schedule 4 prescription-only medication. With medical authority from a doctor, a three month’s supply of
Fig 14.2: ‘NovoRapid’ rapid acting insulin ampoule, 1000U in 10ml with 0.5ml syringe for subcutaneous administration
NOTE: 20 full syringes would need to be quickly injected to administer 1000U